Dr. Chris Wu is a Professor of Translational Medicine at Taipei Medical University, with joint appointments in the Graduate Institute of Biomedical Informatics and multiple interdisciplinary research centers, including the Center for Thoracic Medicine and the Center for Cell Therapy and Regenerative Medicine. Dr. Wu’s research expertise spans antibody-drug conjugates (ADCs), targeted cancer therapies, cancer cell biology, and the study of galectins in liver diseases. He has led academic programs in translational medicine at both the master’s and doctoral levels and played a key role in advancing international academic collaboration at Taipei Medical University.

Education

• Ph.D., Institute of Basic Medical Sciences, National Cheng Kung University

• Master's Degree, Institute of Biochemistry, National Cheng Kung University

• Bachelor's Degree, Department of Medical Technology, Kaohsiung Medical University

Key skills

• Antibody-Drug Conjugate (ADC) Development

• Cancer Targeted Therapy Research

• Cancer Cell Biology and Molecular Mechanisms

• Translational Medicine Program Leadership

• Galectin Biology and Liver Disease Research